| Name | 1H-Pyrazolo[3,4-g]quinoline, 4,4a,5,6,7,8,8a,9-octahydro-7-[(methylthio)methyl]-5-propyl-, (4aR,8aR)-rel |
|---|---|
| Synonyms | Neuromuscular Disorder-Targeting Compound 1 |
| Description | Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome. |
|---|---|
| Related Catalog | |
| In Vitro | Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome[1]. |
| References |
| Molecular Formula | C15H25N3S |
|---|---|
| Molecular Weight | 279.4 |
| Exact Mass | 279.17691898 |